Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

NCT ID: NCT05324033

Last Updated: 2023-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2023-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is a cornerstone in the treatment plans.Therefore, this study will try to evaluate the sensitivity and reliability of mpMRI in accurate diagnosis of cancer bladder.

Primary objective: to detect the sensitivity of multiparametric MRI in differentiation between muscle Invasive and non-muscle invasive Urinary Bladder Cancer in relation to the conventional cystoscopy and histopathological examination of the biopsy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer, Bladder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

muscle invasive cancer bladder

multiparametric MRI on the bladder

Intervention Type RADIATION

comparison between mpMRI and histopathology

diagnostic cystoscopy +/- TURBT

Intervention Type PROCEDURE

conventional way of diagnosis

non-muscle invasive cancer bladder

multiparametric MRI on the bladder

Intervention Type RADIATION

comparison between mpMRI and histopathology

diagnostic cystoscopy +/- TURBT

Intervention Type PROCEDURE

conventional way of diagnosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multiparametric MRI on the bladder

comparison between mpMRI and histopathology

Intervention Type RADIATION

diagnostic cystoscopy +/- TURBT

conventional way of diagnosis

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients diagnosed with NMIBC or MIBC during diagnostic cystoscopy or by any radiologic investigation in the Urology department of Helwan university hospitals without being restricted to age or sex.
* All histological types of bladder cancer
* Newly diagnosed, recurrent cases, or even patients undergoing follow-up cystoscopy.

Exclusion Criteria

* Patients with elevated renal function according to their age as this will be a contraindication to DCE MRI.
* Patients with absolute contraindication to MRI (e.g.: metallic prosthesis).
* Patients with contraindication to undergo TURBT (e.g.: unfit for surgery).
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helwan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Omar Mohammad Nagib

Assistant lecturer of urosurgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of medicine, Helwan university

Badr, Cairo Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2020 Apr;203(4):706-712. doi: 10.1097/JU.0000000000000617. Epub 2019 Oct 23.

Reference Type BACKGROUND
PMID: 31642740 (View on PubMed)

Shampo MA, Kyle RA, Steensma DP. Richard Ernst--Nobel Prize for nuclear magnetic resonance spectroscopy. Mayo Clin Proc. 2012 Dec;87(12):e109. doi: 10.1016/j.mayocp.2012.01.023. No abstract available.

Reference Type BACKGROUND
PMID: 23218094 (View on PubMed)

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2015 Jun;67(6):1042-1050. doi: 10.1016/j.eururo.2014.11.043. Epub 2014 Dec 8.

Reference Type BACKGROUND
PMID: 25496767 (View on PubMed)

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26.

Reference Type BACKGROUND
PMID: 28456635 (View on PubMed)

Chavhan, G. (2013). MRI Made Easy (for beginners) (2nd ed., pp. 2-16). JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD.

Reference Type BACKGROUND

Cheung G, Sahai A, Billia M, Dasgupta P, Khan MS. Recent advances in the diagnosis and treatment of bladder cancer. BMC Med. 2013 Jan 17;11:13. doi: 10.1186/1741-7015-11-13.

Reference Type BACKGROUND
PMID: 23327481 (View on PubMed)

DeGeorge KC, Holt HR, Hodges SC. Bladder Cancer: Diagnosis and Treatment. Am Fam Physician. 2017 Oct 15;96(8):507-514.

Reference Type BACKGROUND
PMID: 29094888 (View on PubMed)

Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov 5.

Reference Type BACKGROUND
PMID: 31699526 (View on PubMed)

Ghai S, Haider MA. Multiparametric-MRI in diagnosis of prostate cancer. Indian J Urol. 2015 Jul-Sep;31(3):194-201. doi: 10.4103/0970-1591.159606.

Reference Type BACKGROUND
PMID: 26166962 (View on PubMed)

Petralia G, Summers PE, Agostini A, Ambrosini R, Cianci R, Cristel G, Calistri L, Colagrande S. Dynamic contrast-enhanced MRI in oncology: how we do it. Radiol Med. 2020 Dec;125(12):1288-1300. doi: 10.1007/s11547-020-01220-z. Epub 2020 May 15.

Reference Type BACKGROUND
PMID: 32415476 (View on PubMed)

Hawkes RC, Holland GN, Moore WS, Worthington BS. Nuclear magnetic resonance (NMR) tomography of the brain: a preliminary clinical assessment with demonstration of pathology. J Comput Assist Tomogr. 1980 Oct;4(5):577-86. doi: 10.1097/00004728-198010000-00001.

Reference Type BACKGROUND
PMID: 6967878 (View on PubMed)

Huang L, Kong Q, Liu Z, Wang J, Kang Z, Zhu Y. The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. Radiology. 2018 Feb;286(2):502-511. doi: 10.1148/radiol.2017171028. Epub 2017 Dec 4.

Reference Type BACKGROUND
PMID: 29206594 (View on PubMed)

Kagawa T, Yoshida S, Shiraishi T et al., Basic principles of magnetic resonance imaging for beginner oral and maxillofacial radiologists. Oral Radiol 33, 92-100 (2017).

Reference Type BACKGROUND

Kelly, C. R., & Landman, J. (2012, March 29). The Netter Collection of Medical Illustrations - Urinary System. saunders elsevier.

Reference Type BACKGROUND

Margel D, Alkhateeb SS, Finelli A, Fleshner N. Diminished efficacy of Bacille Calmette-Guerin among elderly patients with nonmuscle invasive bladder cancer. Urology. 2011 Oct;78(4):848-54. doi: 10.1016/j.urology.2011.04.070. Epub 2011 Aug 16.

Reference Type BACKGROUND
PMID: 21840578 (View on PubMed)

Nikolaev A, Knipe H, Bell D. (2020). Vesical Imaging-Reporting and Data System (VI-RADS) | Radiology Reference Article | Radiopaedia.org. Vesical Imaging-Reporting and Data System (VI-RADS) | Radiology Reference Article | Radiopaedia.org. Retrieved January 27, 2023, from https://radiopaedia.org/articles/vesical-imaging-reporting-and-data-system-vi-rads-2

Reference Type BACKGROUND

Oeyen E, Hoekx L, De Wachter S, Baldewijns M, Ameye F, Mertens I. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles. Int J Mol Sci. 2019 Feb 14;20(4):821. doi: 10.3390/ijms20040821.

Reference Type BACKGROUND
PMID: 30769831 (View on PubMed)

Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010 Feb;105(3):300-8. doi: 10.1111/j.1464-410X.2009.09076.x. Epub 2009 Nov 13.

Reference Type BACKGROUND
PMID: 19912200 (View on PubMed)

Standring, S., Anand, N., Birch, R., Collins, P., Crossman, A., & Gleeson , M. (2016). Anatomy GRAY'S The Anatomical Basis of Clinical Practice (41st ed., pp. 1254-1313). Elsevier Limited

Reference Type BACKGROUND

Wang H, Luo C, Zhang F, Guan J, Li S, Yao H, Chen J, Luo J, Chen L, Guo Y. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion. Radiology. 2019 Jun;291(3):668-674. doi: 10.1148/radiol.2019182506. Epub 2019 Apr 23.

Reference Type BACKGROUND
PMID: 31012814 (View on PubMed)

Westbrook, C., Roth, C., & Talbot, J. (2011). MRI in Practice (4th ed., pp. 397-403). A John Wiley & Sons, Ltd., Publication.

Reference Type BACKGROUND

Withey SJ, Christodoulou D, Prezzi D, Rottenberg G, Sit C, Ul-Hassan F, Carroll P, Velusamy A, Izatt L, Nair R, Jacques AET. Bladder paragangliomas: a pictorial review. Abdom Radiol (NY). 2022 Apr;47(4):1414-1424. doi: 10.1007/s00261-022-03443-2. Epub 2022 Feb 14.

Reference Type BACKGROUND
PMID: 35157102 (View on PubMed)

Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis. Eur J Radiol. 2017 Oct;95:46-55. doi: 10.1016/j.ejrad.2017.07.021. Epub 2017 Jul 29.

Reference Type BACKGROUND
PMID: 28987698 (View on PubMed)

Zhu CZ, Ting HN, Ng KH, Ong TA. A review on the accuracy of bladder cancer detection methods. J Cancer. 2019 Jul 8;10(17):4038-4044. doi: 10.7150/jca.28989. eCollection 2019.

Reference Type BACKGROUND
PMID: 31417648 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-FMHU 51/2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Can VI-RADS/ADC Accurately Stage Bladder Cancer??
NCT04167631 ACTIVE_NOT_RECRUITING NA
3 Tesla MRI in Patients With Bladder Cancer
NCT00938145 ACTIVE_NOT_RECRUITING NA